Overexpression of TRAF3 in GBM cells induced the accumulation of unmetabolized PUFAs and peroxidation mitochondrial damage, leading to increased sensitivity of GBM to ferroptosis and anti–PD-L1 immunotherapy, which indicates a promising strategy for GBM treatment. Here, TRAF3 is linked to glioblastoma.